Stock Market News2 days Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here’s Why Investor's Business Daily
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025.
The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business …